Showing results (371-380 of 2,105) with videos related to
Sort By:
Pageof 211
CNS Drugs|August 28, 2020
Adjunctive Cenobamate for Focal-Onset Seizures in Adults: A Systematic Review and Meta-AnalysisSimona Lattanzi, Eugen Trinka, Gaetano Zaccara, et al.CNS Drugs|March 31, 2018
Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010Simon Faissner, Ralf GoldCNS Drugs|December 7, 2019
Cognitive Impairment in Patients with Bipolar Disorder: Impact of Pharmacological TreatmentNi Xu, Benjamin Huggon, Kate E A SaundersCNS Drugs|February 12, 2019
Tranexamic Acid in Cerebral Hemorrhage: A Meta-Analysis and Systematic ReviewWenyu Hu, Yanguo Xin, Xin Chen, et al.CNS Drugs|February 14, 2019
Treatment Strategies for Clozapine-Induced Sialorrhea: A Systematic Review and Meta-analysisShih-Yu Chen, Gopi Ravindran, Qichen Zhang, et al.CNS Drugs|January 30, 2020
Multiple-Ascending Dose Study in Healthy Subjects to Assess the Pharmacokinetics, Tolerability, and CYP3A4 Interaction Potential of the T-Type Calcium Channel Blocker ACT-709478, A Potential New Antiepileptic DrugMuriel Richard, Priska Kaufmann, Marion Ort, et al.CNS Drugs|September 3, 2020
Fenfluramine for the Treatment of Dravet Syndrome and Lennox-Gastaut SyndromeGanna Balagura, Marta Cacciatore, Eleonora A Grasso, et al.CNS Drugs|September 19, 2020
Rapidity of CNS Effect on Photoparoxysmal Response for Brivaracetam vs. Levetiracetam: A Randomized, Double-blind, Crossover Trial in Photosensitive Epilepsy PatientsRonald C Reed, William E Rosenfeld, Susan M Lippmann, et al.CNS Drugs|February 6, 2016
Potential Role of Oestrogen Modulation in the Treatment of Neurocognitive Deficits in SchizophreniaThomas W Weickert, Katherine M Allen, Cynthia S WeickertCNS Drugs|January 24, 2016
A Systematic Review and Network Meta-Analysis to Assess the Relative Efficacy of Antipsychotics for the Treatment of Positive and Negative Symptoms in Early-Onset SchizophreniaRebecca C Harvey, Anthony C James, Gemma E ShieldsPageof 211